Società Neurokine Pharmaceuticals Inc Other OTC
Azioni
CAC611561100
Biotecnologia
Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
|
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
David Melles
IRC | Investor Relations Contact | - | 29/09/21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05/05/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 122 729 397 | 90 632 281 ( 73,85 %) | 0 | 73,85 % |
Coordinate società
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+
http://www.abetterlifepharma.com![Indirizzo Neurokine Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/17068088.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,12% | 126 Mrd | |
+23,26% | 118 Mrd | |
+23,26% | 27,87 Mrd | |
-18,44% | 20,95 Mrd | |
-15,13% | 16,92 Mrd | |
-13,53% | 16,18 Mrd | |
+9,94% | 14,84 Mrd | |
-46,10% | 14,79 Mrd | |
+51,98% | 14,08 Mrd |
- Borsa valori
- Azioni
- Azione BETRF
- Azione
- Società Neurokine Pharmaceuticals Inc